Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10140429 | 0.85 | CA14 (0.31) | CA14CA12CA1CA2 | |
| SCHEMBL9634202 | 0.84 | CA14 (0.36) | CA14CA12CA1CA2DGAT1 | |
| SCHEMBL9634197 | 0.84 | CA14 (0.36) | CA14CA12CA1CA2DGAT1 | |
| SCHEMBL15562451 | 0.81 | CA14 (0.36) | CA14CA12CA1CA2DGAT1 | |
| SCHEMBL15455290 | 0.81 | CA14 (0.36) | CA14CA12CA1CA2DGAT1 | |
| SCHEMBL16284716 | 0.80 | CA14 (0.33) | CA14CA12CA1CA2DGAT1 | |
| SCHEMBL3602393 | 0.80 | HDAC6 (0.36) | CA14CA12CA1CA2DGAT1 | |
| SCHEMBL12475550 | 0.80 | CTSK (0.35) | CA14CA12CA1CA2DGAT1 | |
| SCHEMBL12475555 | 0.80 | CTSK (0.35) | CA14CA12CA1CA2DGAT1 | |
| SCHEMBL15434471 | 0.79 | CA14 (0.32) | CA14CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958395-B2 | Method for producing water-soluble saccharide conjugates and saccharide mimetics by Diels-Alder reaction | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) | 2005-10-25 | — | — | US | disclosed |
| US-20040059101-A1 | Method for producing water-soluble saccharide conjugates and saccharide mimetics by diels-alder reaction | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040059101-A1 | Method for producing water-soluble saccharide conjugates and saccharide mimetics by diels-alder reaction | SI, MAN1B1, SORD | CA14 51/4885CA12 102/4885CA1 132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.